An ISCIII study supports the third dose due to the decrease in antibodies at 6 months.

Media coverage

• Title	An ISCIII study supports the third dose due to the decrease in antibodies at 6 months.
  Media name/outlet	CE Noticias Financieras English
  Country/Territory	United States
  Date	1/08/22
  Persons	Jordi Ochando

• Title	Spanish study supports the third dose due to the decrease of antibodies at 6 months of age
  Media name/outlet	CE Noticias Financieras English
  Country/Territory	United States
  Date	1/08/22
  Persons	Jordi Ochando